Aims: To review all the case reports or case series of patients with adult hepatoblastoma. Methods: A search of all case reports on adult hepatoblastoma in the English literature was performed using the PubMed database. Demographic information, clinical findings, treatment modalities and outcomes were extracted and analyzed. Results: A total of 36 English articles and 40 patients with adult hepatoblastoma were collected. All these cases were confirmed by pathological diagnosis. The median age of the 40 patients was 41.5 years, including 21 males and 19 females. Hepatitis B virus tests were positive in 6 patients, and 15 patients were positive for α-fetoprotein (AFP). Liver cirrhosis was only confirmed in 7 cases. Hepatoblastoma commonly forms a single giant mass within the liver. Twenty-three cases underwent radical liver resection, including 9 cases of comprehensive treatment. The median survival time for 27 patients with available follow-ups was 4 months; 1-year survival was 29.6%. In Cox multivariate analysis, curative liver resection was an independent prognostic factor for prolonged survival (p = 0.003). Conclusions: Curative liver resection can prolong survival. Improvements in outcome will require the development of more effective systemic therapies.

Keywords:
Hepatoblastoma, Adult, Systemic review
1.
Litten JB, Tomlinson GE: Liver tumors in children. Oncologist 2008;13:812–820.
2.
Primary liver cancer in Japan: Clinicopathologic features and results of surgical treatment. Liver Cancer Study Group of Japan. Ann Surg 1990;211:277–287.
3.
Ang JP, Heath JA, Donath S, et al: Treatment outcomes for hepatoblastoma: an institution’s experience over two decades. Pediatr Surg Int 2007;23:103–109.
4.
Yamazaki M, Ryu M, Okazumi S, et al: Hepatoblastoma in an adult: a case report and clinical review of literatures. Hepatol Res 2004;30:182–188.
5.
Barnett WH, Erickson EE, Halpert B: Embryonic tumor of the liver in an adult. Cancer 1958;11:306–309.
6.
Alexander MK: A mixed tumour of the liver in an adult. J Pathol Bacteriol 1961;82:217–219.
7.
Ojima A, Sugiyama T, Takeda T, et al: Six cases of rare malignant tumors of the liver. Acta Pathol Jpn 1964;14:95–102.
8.
Blanding JD: Mixed malignant tumor of the liver in an adult. Case report and review of some features. Arch Pathol 1968;86:108–110.
9.
Carter R: Hepatoblastoma in the adult. Cancer 1969;23:191–197.
10.
Kerr JF: Hepatic embryonic mixed tumour in an adult. J Pathol Bacteriol 1966;92:238–240.
11.
Goldman RL, Friedman NB: Rhabdomyosarcohepatoma in an adult and embryonal hepatoma in a child. Am J Clin Pathol 1969;51:137–143.
12.
Meyer P, LiVolsi V, Cornog JL: Letter: hepatoblastoma associated with an oral contraceptive. Lancet 1974;ii:1387.
13.
Ludwig J, Grier MW, Hoffman IH, et al: Calcified mixed malignant tumor of the liver. Arch Pathol 1975;99:162–166.
14.
Jameson CP, Chatkadakis CB: Hepatoblastoma in a middle-aged white South African woman. A case report. S Afr Med J 1978;53:143–144.
15.
Honan RP, Haqqani MT: Mixed hepatoblastoma in the adult: case report and review of the literature. J Clin Pathol 1980;33:1058–1063.
16.
Kishimoto Y, Hijiya S, Nagasako R: Malignant mixed tumor of the liver in adults. Am J Gastroenterol 1984;79:229–235.
17.
Kawarada Y, Uehara S, Noda M, et al: Nonhepatocytic malignant mixed tumor primary in the liver. Report of two cases. Cancer 1985;55:1790–1798.
18.
Sugino K, Dohi K, Matsuyama T, et al: A case of hepatoblastoma occurring in an adult. Jpn J Surg 1989;19:489–493.
19.
Altmann HW: Epithelial and mixed hepatoblastoma in the adult. Histological observations and general considerations. Pathol Res Pract 1992;188:16–26.
20.
Anderson BB, Ukah F, Tette A, et al: Primary tumors of the liver. J Natl Med Assoc 1992;84:129–135.
21.
Harada T, Matsuo K, Kodama S, et al: Adult hepatoblastoma: case report and review of the literature. Aust NZ J Surg 1995;65:686–688.
22.
Inoue S, Nagao T, Ishida Y, et al: Successful resection of a large hepatoblastoma in a young adult: report of a case. Surg Today 1995;25:974–977.
23.
Kacker LK, Khan EM, Gupta R, et al: Hepatoblastoma in an adult with biliary obstruction and associated portal venous thrombosis. HPB Surg 1995;9:47–49.
24.
Bortolasi L, Marchiori L, Dal Dosso I, et al: Hepatoblastoma in adult age: a report of two cases. Hepatogastroenterology 1996;43:1073–1078.
25.
Ahn HJ, Kwon KW, Choi YJ, et al: Mixed hepatoblastoma in an adult – a case report and literature review. J Korean Med Sci 1997;12:369–373.
26.
Parada LA, Bardi G, Hallen M, et al: Cytogenetic abnormalities and clonal evolution in an adult hepatoblastoma. Am J Surg Pathol 1997;21:1381–1386.
27.
Inagaki M, Yagi T, Urushihara N, et al: Successfully resected hepatoblastoma in a young adult with chronic hepatitis B: report of a case. Eur J Gastroenterol Hepatol 2001;13:981–984.
28.
Ke HY, Chen JH, Jen YM, et al: Ruptured hepatoblastoma with massive internal bleeding in an adult. World J Gastroenterol 2005;11:6235–6237.
29.
Kasper HU, Longerich T, Stippel DL, et al: Mixed hepatoblastoma in an adult. Arch Pathol Lab Med 2005;129:234–237.
30.
Remes-Troche JM, Montano-Loza A, Meza-Junco J, et al: Hepatoblastoma in adult age. A case report and literature review. Ann Hepatol 2006;5:179–181.
31.
Nakamura S, Sho M, Kanehiro H, et al: Adult hepatoblastoma successfully treated with multimodal treatment. Langenbecks Arch Surg 2010;395:1165–1168.
32.
Seabrook GR, Collin JR, Britton BJ: Hepatoblastoma: successful resection in an adult. Br J Clin Pract 1989;43:345–346.
33.
Oda H, Honda K, Hara M, et al: Hepatoblastorna in an 82-year-old man. Acta Pathologica Japonica1990;40:212–218.
34.
Hiroki K, Wataru Y, Fumio S, et al: Hepatoblastoma in an adult associated with c-met proto-oncogene imbalance. Pathol Int 1996; 46:1005–1010.
35.
Zhang SH, Xu AM, Lin WH, et al: Mixed hepatoblastoma with teratoid features in an adult. Pathology 2007;39:453–456.
36.
Dumortier J, Bizollon T, Chevallier M, et al: Recurrence of hepatocellular carcinoma as a mixed hepatoblastoma after liver transplantation. Gut 1999;45:622–625.
37.
Di Benedetto F, Di Sandro S, D’Amico G, et al: Role of chemoembolization as a rescue treatment for recurrence of resected hepatoblastoma in adult patients. Surg Innov 2011;18:136–140.
38.
Scatarige JC, Fishman EK, Saksouk FA, et al: Computed tomography of calcified liver masses. J Comput Assist Tomogr 1983;7:83–89.
39.
Fiaschetti V, Fiori R, Gaspari E, et al: Mixed hepatoblastoma in a young male adult: a case report and literature review. Case Report Med 2010;2010:919457.
40.
Slugen I, Fiala P, Pauer M, et al: Mixed hepatoblastoma in the adult: morphological and immunohistochemical findings. Bratisl Lek Listy 1990;91:507–515.
41.
Weber RG, Pietsch T, von Schweinitz D, et al: Characterization of genomic alterations in hepatoblastomas. A role for gains on chromosomes 8q and 20 as predictors of poor outcome. Am J Pathol 2000;157:571–578.
42.
Koch A, Waha A, Hartmann W, et al: Elevated expression of Wnt antagonists is a common event in hepatoblastomas. Clin Cancer Res 2005;11:4295–4304.
43.
Bruix J, Sherman M: Management of hepatocellular carcinoma. Hepatology 2005;42:1208–1236.
44.
Weinberg AG, Finegold MJ: Primary hepatic tumors of childhood. Hum Pathol 1983;14:512–537.
45.
Ishak KG, Glunz PR: Hepatoblastoma and hepatocarcinoma in infancy and childhood. Report of 47 cases. Cancer 1967;20:396–422.
46.
Rougemont AL, McLin VA, Toso C, et al: Adult hepatoblastoma: Learning from children. J Hepatol 2012;56:1392–1403.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.